Background Neuraminidase inhibitors (NIs) are stockpiled and recommended by public
health agencies for treating and preventing seasonal and pandemic influenza. They are used …

Background There have been no studies of the patterns of post-marketing withdrawals of
medicinal products to which adverse reactions have been attributed. We identified medicinal …

Objective To describe the potential benefits and harms of oseltamivir by reviewing all clinical
study reports (or similar document when no clinical study report exists) of randomised …

Background The introduction of point‐of‐care devices for the management of patients on oral
anticoagulation allows self‐testing by the patient at home. Patients who self‐test can either …

Background Current methods of improving medication adherence for health problems are
mostly complex, labour‐intensive, and not reliably effective. Medication'reminder packaging', …

Background Neuraminidase inhibitors (NI) are recommended for use against influenza and
its complications in inter‐pandemic years and during pandemics. Objectives To assess the …

Background The introduction of portable monitors (point‐of‐care devices) for the management
of patients on oral anticoagulation allows self‐testing by the patient at home. Patients who …

… Carl J Heneghan professor of evidence based medicine1, Igho Onakpoya research fellow
in evidence based practice and pharmacovigilance1, Matthew Thompson Helen D Cohen …

Background: Airborne transmission is the spread of an infectious agent caused by the
dissemination of droplet nuclei (aerosols) that remain infectious when suspended in the air. We …

OBJECTIVE Middle-aged people with diabetes have been reported to have significantly
higher risks of cardiovascular events than people without diabetes. However, recent falls in …